Literature DB >> 18223132

The IFCC Reference Measurement System for HbA1c: a 6-year progress report.

Cas Weykamp1, W Garry John, Andrea Mosca, Tadao Hoshino, Randie Little, Jan-Olof Jeppsson, Ian Goodall, Kor Miedema, Gary Myers, Hans Reinauer, David B Sacks, Robbert Slingerland, Carla Siebelder.   

Abstract

BACKGROUND: The IFCC Reference Measurement System for hemoglobin (Hb)A(1c) (IFCC-RM) has been developed within the framework of metrologic traceability and is embedded in a network of 14 reference laboratories. This paper describes the outcome of 12 intercomparison studies (periodic evaluations to control essential elements of the IFCC-RM).
METHODS: Each study included: unknown samples (to test individual network laboratories); known samples (controls); recently manufactured calibrators (to check calculated assigned value); stored calibrators (to test stability) and a calibration-set (to calibrate the IFCC-RM). The unknown samples are measured by use of the IFCC-RM and the designated comparison methods [DCMs; the National Glycohemoglobin Standardization Program (NGSP) in the US, Japanese Diabetes Society/Japanese Society for Clinical Chemistry (JDS/JSCC) in Japan, and Mono-S in Sweden] are used to investigate the stability of the Master Equation (ME), the relationship between IFCC-RM and DCMs.
RESULTS: A total of 105 IFCC-RM data sets were evaluated: 95 were approved, 5 were not, and for 5 no data were submitted. Trend analysis of the MEs, expressed as change in percentage HbA(1c) per year, revealed 0.000% (NGSP, not significant), -0.030%, (JDS/JSCC; significant) and -0.016% (Mono-S; not significant). Evaluation of long-term performance revealed no systematic change over time; 2 laboratories showed significant bias, 1 poor reproducibility. The mean HbA(1c) determined by laboratories performing mass spectrometry (MS) was the same as the mean determined by laboratories using capillary electrophoresis (CE), but the reproducibility at laboratories using CE was better. One batch of new calibrators was not approved. All stored calibrators were stable.
CONCLUSION: A sound reference system is in place to ensure continuity and stability of the analytical anchor for HbA(1c).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223132     DOI: 10.1373/clinchem.2007.097402

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  36 in total

1.  Thymic emigration patterns in patients with type 2 diabetes treated with metformin.

Authors:  Grzegorz Dworacki; Olzhas Urazayev; Yerbol Bekmukhambetov; Saule Iskakova; Bartosz A Frycz; Paweł P Jagodziński; Marzena Dworacka
Journal:  Immunology       Date:  2015-10-05       Impact factor: 7.397

2.  Comparison of Arkray/ELITech ADAMS HA-8180V with Bio-Rad Variant, II Turbo2.0 and Tosoh Bioscience HLC-723G8 for HbA1c determination.

Authors:  Stéphanie Badiou; Julie Guillot; Nils Kuster; Anne-Sophie Bargnoux; Patricia Aguilar-Martinez; Elodie Boissier; Jean-Paul Cristol; Anne-Marie Dupuy
Journal:  J Clin Lab Anal       Date:  2014-03-20       Impact factor: 2.352

3.  The implementation of international standardization of glycated hemoglobin. A "red-letter-day" for glycated hemoglobin in Italy: 1/1/11. Italian Recommendations of GLAD Working Group (A1c delegates WG).

Authors:  A Mosca; D Iafusco; F Meschi; M T Branca; M Carta; M L Genna; C B Giorda; R Ghidelli; G Ghislandi; A Lapolla; V Buondonno Lombardi; C A Lovagnini; M Marra; G Medea; A Pizzini; F Rossi; R Scalpone; G Tofini; M Trovati; M Zaninotto
Journal:  J Endocrinol Invest       Date:  2011-05-31       Impact factor: 4.256

4.  Evaluation of turbidimetric inhibition immunoassay (TINIA) and HPLC methods for glycated haemoglobin determination.

Authors:  Sema Genc; Beyhan Omer; Esra Aycan-Ustyol; Nurhan Ince; Fatih Bal; Figen Gurdol
Journal:  J Clin Lab Anal       Date:  2012-11       Impact factor: 2.352

5.  A semi-mechanistic model of the relationship between average glucose and HbA1c in healthy and diabetic subjects.

Authors:  Rocío Lledó-García; Norman A Mazer; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-01-10       Impact factor: 2.745

6.  LDL cholesterol performance of beta quantification reference measurement procedure.

Authors:  Masakazu Nakamura; Yuzo Kayamori; Hiroyasu Iso; Akihiko Kitamura; Masahiko Kiyama; Isao Koyama; Kunihiro Nishimura; Michikazu Nakai; Hiroyuki Noda; Mahnaz Dasti; Hubert W Vesper; Yoshihiro Miyamoto
Journal:  Clin Chim Acta       Date:  2014-02-28       Impact factor: 3.786

7.  Predisposing factors for surgical site infection of spinal instrumentation surgery for diabetes patients.

Authors:  Kotaro Satake; Tokumi Kanemura; Akiyuki Matsumoto; Hidetoshi Yamaguchi; Yoshimoto Ishikawa
Journal:  Eur Spine J       Date:  2013-04-24       Impact factor: 3.134

8.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

9.  A1C for screening and diagnosis of type 2 diabetes in routine clinical practice.

Authors:  Zhong X Lu; Karen Z Walker; Kerin O'Dea; Ken A Sikaris; Jonathan E Shaw
Journal:  Diabetes Care       Date:  2010-01-12       Impact factor: 17.152

10.  2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement.

Authors:  Ragnar Hanas; Garry John
Journal:  Diabetes Care       Date:  2010-06-02       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.